ALFRED AINSLEY DURHAM, M.D.

SALEM, VA

Research Active
Orthopaedic Surgery NPI registered 21+ years 50 publications 2012 – 2026 NPI: 1306841887
MiceMice, Inbred C57BLSignal TransductionMelanomaLung NeoplasmsPilot ProjectsCarcinoma, Non-Small-Cell LungImmunotherapyNeoplasm Recurrence, LocalDogsRadiosurgeryWatchful WaitingHorse DiseasesRectal NeoplasmsOptical Imaging

Practice Location

1802 BRAEBURN DR
SALEM, VA 24153-7357

Phone: (540) 772-3530

What does ALFRED DURHAM research?

Dr. Durham studies the effectiveness of different cancer treatments in humans and veterinary medicine for horses. His work includes identifying genes that predict how well rectal cancer patients will respond to treatments like chemoradiotherapy, which combines chemotherapy and radiation. He also investigates how certain hormones relate to health conditions in older horses, particularly pituitary pars intermedia dysfunction (PPID). Additionally, his research addresses the treatment of opioid addiction and health disparities in Alzheimer’s disease, focusing on how to better support marginalized communities in the healthcare system.

Key findings

  • In horses, those with pituitary pars intermedia dysfunction showed an average beta-endorphin level of 291 pg/mL compared to healthy older horses at 55 pg/mL, aiding in better diagnostic practices for veterinarians.
  • A study on rectal cancer found 186 genes that predict chemoradiotherapy response with an accuracy score of 0.80, helping clinicians identify patients who are most likely to benefit from this treatment.
  • For patients with localized rectal cancer, a systematic review showed that 100% of those with a specific cancer type (MSI-H) achieved a complete response to neoadjuvant immunotherapy, potentially allowing them to avoid surgery.
  • In a study on women during prenatal care, over 30% reported experiencing disrespect and mistreatment, emphasizing the need for improved healthcare practices for Black women.
  • Research into opioid addiction revealed that antibody immunotherapies could block the effects of opioids in the brain, leading to better recovery outcomes.

Frequently asked questions

Does Dr. Durham study cancer treatments?
Yes, Dr. Durham studies various cancer treatments, focusing on how well patients respond to therapies such as chemoradiotherapy and immunotherapy.
What did Dr. Durham find about older horses?
He found that older horses with pituitary pars intermedia dysfunction have significantly higher levels of beta-endorphin, which can help veterinarians diagnose their conditions more effectively.
Is Dr. Durham's work relevant to health disparities?
Yes, he investigates health inequities, particularly in how Black women experience prenatal care, aiming to improve treatment and understanding in this area.
What treatments has Dr. Durham researched for opioid addiction?
He has looked into antibody immunotherapies that can effectively help individuals overcome opioid addiction by blocking the effects of drugs in the brain.
How does Dr. Durham's research aid dog health?
He studies treatments for cancer in dogs, including methods for identifying key lymph nodes affected by thyroid carcinoma, which can influence treatment decisions.

Publications in plain English

Integrative analysis of transcriptomic data reveals a predictive gene signature for chemoradiotherapy response in rectal cancer.

2026

iScience

Corrò C, Carvalho JVM, Rapti M, Angelino P, Tihy M +12 more

Plain English
This study focused on finding a set of genes that can predict how well patients with locally advanced rectal cancer will respond to a specific treatment called neoadjuvant chemoradiotherapy. Researchers identified a group of 186 genes that accurately predicted treatment response, with a high accuracy score (AUC of 0.80), which means they can help identify patients most likely to benefit from this therapy. Understanding which patients will respond to treatment can lead to better treatment decisions and improved outcomes. Who this helps: This helps patients with locally advanced rectal cancer by guiding their treatment options.

PubMed

Associations among beta-endorphin, ACTH, cortisol concentration, age, and clinical signs indicative of pituitary pars intermedia dysfunction in geriatric horses.

2026

Journal of veterinary internal medicine

Billmann P, Durham A, Christen G, Savioli G, Gross JJ +2 more

Plain English
This study looked at older horses (aged 18-32 years) to see how certain hormones and physical signs related to a condition called pituitary pars intermedia dysfunction (PPID). Researchers found that horses with PPID had higher levels of a hormone called beta-endorphin, averaging 291 pg/mL, compared to healthy older horses, which had an average of 55 pg/mL. Understanding these differences helps veterinarians identify whether changes in an older horse's health are due to normal aging or a specific illness like PPID. Who this helps: This helps veterinarians diagnose and treat older horses.

PubMed

Azacitidine-induced remission enables allogeneic transplantation in/-mutant relapsed extranodal natural killer/T-cell lymphoma: a case report.

2026

Haematologica

Ortiz CR, Abouzeid H, De Bernardi C, Durham A, Mathoux G +7 more

PubMed

The Role of the Neural Exposome as a Novel Strategy to Identify and Mitigate Health Inequities in Alzheimer's Disease and Related Dementias.

2025

Molecular neurobiology

Granov R, Vedad S, Wang SH, Durham A, Shah D +1 more

Plain English
This research paper looks at how a concept called the "neural exposome" can help understand and reduce health inequalities in Alzheimer's disease and related dementias. The study emphasizes the need to consider various social, environmental, and behavioral factors that affect brain health, especially in disadvantaged communities. By using tools like machine learning, the goal is to identify different risk factors for Alzheimer’s and improve treatment strategies that address these inequalities. Who this helps: This research benefits patients, especially those from underrepresented communities, by promoting equitable healthcare.

PubMed

Response to: Certifying "day one ready" pathologists: are we accomplishing our goals?

2025

Veterinary pathology

Diehl L, Ritchey J, Reams R, Durham A, Alves T +7 more

PubMed

Optimal Timing of Primary Radiosurgical Treatment of Growing Vestibular Schwannoma: Insights From Salvage Microsurgery Outcomes.

2025

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Marinelli JP, Herberg HA, Moore LS, Yancey KL, Kay-Rivest E +17 more

Plain English
This study looked at the best timing for treating growing vestibular schwannomas (benign tumors on a nerve near the ear) with radiosurgery and how this affects later surgery outcomes when the initial treatment fails. Researchers examined 96 patients, finding that for every 1 mm increase in tumor size at the first treatment, patients were 13% more likely to have a successful surgery later and 9% more likely to experience complications. The results indicate that radiosurgery works best when done on tumors that are between 10 mm and 15 mm in size. Who this helps: This information benefits patients with vestibular schwannomas and their doctors, guiding treatment decisions.

PubMed

A combination of pre- and intraoperative techniques identifies sentinel lymph nodes in dogs with thyroid carcinoma: A pilot study.

2025

Veterinary surgery : VS

Griffin MA, Worley DR, Flesner BK, Reetz J, Holt DE +4 more

Plain English
This study looked at methods to identify important lymph nodes in dogs with thyroid cancer before and during surgery. Researchers tested a technique on six dogs and successfully found at least one key lymph node in every case, using imaging and dyes; specifically, they found that two out of the six dogs had cancer spread to these lymph nodes. This research is important because finding and removing these key lymph nodes can help determine how far the cancer has spread, which can influence treatment plans. Who this helps: This helps veterinarians and dog owners dealing with thyroid cancer in dogs.

PubMed

Antibody immunotherapies for personalized opioid addiction treatment.

2025

The Journal of pharmacology and experimental therapeutics

Rosenn EH, Korlansky M, Benyaminpour S, Munarova V, Fox E +4 more

Plain English
This study looked at using antibody therapies to treat opioid addiction, which are potentially more effective and less expensive than current treatments. The authors reviewed various research findings showing that these therapies can block the effects of opioids in the brain, helping individuals stop using drugs. This approach matters because it could lead to better long-term recovery and address some of the brain damage caused by drug use. Who this helps: This benefits patients struggling with opioid addiction and doctors looking for more effective treatment options.

PubMed

[Pancreatic cancer in 2025 : multidisciplinary management].

2025

Revue medicale suisse

Brito R, Mack S, Bornand A, Cauchy F, Durham A +6 more

Plain English
This research paper looks at pancreatic cancer, which is a tough disease known for having short survival times—typically only 6 to 8 months. It highlights that in Switzerland alone, about 1,700 new pancreatic cancer cases and 1,400 deaths occur each year, mainly because the disease is often diagnosed too late. The study shows advancements in treatments and diagnostic methods, but still emphasizes that pancreatic cancer poses a major challenge to healthcare. Who this helps: This benefits patients with pancreatic cancer and their doctors.

PubMed

Quantitative proteomics unveils potential plasma biomarkers and provides insights into the pathophysiological mechanisms underlying equine metabolic syndrome.

2025

BMC veterinary research

Espinosa-López EM, Ortiz-Guisado B, Diez de Castro E, Durham A, Aguilera-Tejero E +1 more

Plain English
This study focused on understanding Equine Metabolic Syndrome (EMS), a serious condition in horses that leads to obesity, insulin issues, and a painful foot problem called laminitis. Researchers discovered 76 proteins in horse blood that change when EMS is present, which could help develop better tests for early diagnosis. This is important because identifying EMS early can prevent severe health issues and improve horse care. Who this helps: This benefits horse owners and veterinarians dealing with EMS.

PubMed

Narrative Review: Predictive Biomarkers of Tumor Response to Neoadjuvant Radiotherapy or Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer Patients.

2025

Cancers

Machado Carvalho JV, Meyer J, Ris F, Durham A, Bornand A +3 more

Plain English
This study looked at different biological indicators that might help doctors predict how well patients with locally advanced rectal cancer will respond to specific treatments before surgery. The research reviewed 21 articles and found some promising markers, such as low levels of a substance called CEA and certain features seen in MRI scans, which could help identify patients likely to benefit from treatment. These findings matter because they could lead to better treatment decisions, potentially reducing unnecessary exposure to ineffective treatments. Who this helps: This helps patients with locally advanced rectal cancer and their doctors.

PubMed

The Stories We Tell: Black Women's Narratives of Agency, (Dis)Respect, and Resistance During Prenatal Care.

2025

Qualitative health research

Harris NL, Fryer K, Durham A

Plain English
This study looked at the experiences of Black women during prenatal care and found that over 30% reported being disrespected or mistreated, with many facing racism as well. Interviews with 16 women revealed themes around feeling dehumanized, power imbalances in healthcare, and their ability to resist mistreatment. This matters because it sheds light on the need for better understanding and treatment of Black women in medical settings, ensuring they receive care that recognizes their dignity and autonomy. Who this helps: This helps Black women navigating prenatal care.

PubMed

Preliminary evaluation of the safety and feasibility of toll-like receptor ligand CB101 combined with hypofractionated radiation therapy in canine head and neck cancer: a pilot study.

2025

Veterinary oncology (London, England)

Ghanian A, DiBona J, Duda L, Xu X, Lukens JN +6 more

Plain English
This study looked at the safety and practicality of using a new treatment called CB101 alongside radiation therapy for dogs with advanced head and neck cancer. In the trial, three dogs received radiation therapy while getting intratumoral injections of CB101, which targets the immune system to help fight the cancer. The treatment was well-tolerated, with only one minor side effect related to CB101, suggesting it might be a promising option for enhancing cancer treatment in dogs. Who this helps: This benefits dogs with head and neck cancer and their owners by potentially improving treatment options.

PubMed

Correction: Quantitative proteomics unveils potential plasma biomarkers and provides insights into the pathophysiological mechanisms underlying equine metabolic syndrome.

2025

BMC veterinary research

Espinosa-López EM, Ortiz-Guisado B, de Castro ED, Durham A, Aguilera-Tejero E +1 more

PubMed

Impact of Neoadjuvant Immunotherapy in Localized Rectal Cancer. A Systematic Review.

2025

Clinical colorectal cancer

Salihu F, Corro C, Ris F, Meurette G, Durham A +4 more

Plain English
This study looked at the effects of immunotherapy before surgery in patients with locally advanced rectal cancer. It found that patients with a specific type of cancer (microsatellite instability high, or MSI-H) had a complete response to treatment 100% of the time, allowing many to avoid surgery altogether, while patients with microsatellite stable (MSS) cancer had varying outcomes, with surgery rates between 57.6% to 100%. Overall, the research shows promise for using immunotherapy in these patients, but more studies are needed to better understand how it can help those with MSS cancer. Who this helps: This benefits patients with locally advanced rectal cancer, especially those with MSI-H cancer.

PubMed

Sexual attitudes and knowledge of Southern United States college students on risky sexual behavior: moderation by conservative religiosity, sex, and sexual double standards.

2025

Journal of American college health : J of ACH

Durham A, McKinney C

Plain English
This study looked at how sexual attitudes and knowledge influence risky sexual behavior among college students in the Southern United States. Researchers surveyed 967 students and found that for women, higher sexual knowledge and more liberal attitudes led to less engagement in risky sexual behavior, while for men, those with higher sexual knowledge but also strong beliefs in sexual double standards tended to have more positive attitudes toward risky behaviors. The findings highlight that conservative religious beliefs can help protect against risky sexual attitudes, especially for men. Who this helps: This helps college students and educators by illustrating the importance of comprehensive sexual education and addressing harmful beliefs that can lead to risky behavior.

PubMed

Rationale and Design of the AUSTRAL trial: An Open-Label, Multicenter, Phase II Study Evaluating Radiotherapy Followed by Durvalumab (MEDI4736) and Ceralasertib (AZD6738) in Stage III NSCLC Patients With Thoracic Relapses and/or Oligometastases After the PACIFIC Regimen.

2025

Clinical lung cancer

Filippi AR, Rulli E, Signorelli D, Willmann J, Durham A +8 more

Plain English
The AUSTRAL trial is a medical study looking at how well a combination of radiation therapy and two drugs, durvalumab and ceralasertib, works for patients with stage III non-small-cell lung cancer that has returned or spread to a few other sites after initial treatment. The study includes 21 patients who had a relapse after more than a year from their last treatment, and it aims to see how safe and effective this new treatment approach is over about 40 months. This matters because it could provide a second chance for patients who have limited cancer spread, improving their chances of survival and quality of life. Who this helps: This helps patients with stage III non-small-cell lung cancer who experience a relapse.

PubMed

The social work discipline in the management of Failure to thrive in infants and children: an integrated behavioral health approach to pediatric programming.

2024

Social work in health care

Elswick S, West K, Hirschi M, Durham A, Bowden M +1 more

Plain English
This study looked at how social workers help infants and children diagnosed with Failure to Thrive (FTT), which means they aren't growing as expected. It found that using a team approach, including social work, can significantly improve treatment outcomes. For example, treating these children in a primary care facility was shown to be more cost-effective than in a hospital. Who this helps: This helps infants and children with growth issues, along with their families and healthcare providers.

PubMed

Salvage Microsurgery Following Failed Primary Radiosurgery in Sporadic Vestibular Schwannoma.

2024

JAMA otolaryngology-- head & neck surgery

Marinelli JP, Herberg HA, Moore LS, Yancey KL, Kay-Rivest E +17 more

Plain English
This study looked at patients with sporadic vestibular schwannoma who had unsuccessful treatment with radiosurgery and then had surgery to remove the tumor. They followed 126 patients and found that 63% did not have complete tumor removal, and 47% experienced long-term facial weakness after the surgery. This research highlights that even after salvage surgery, many patients may still face significant complications, affecting their quality of life. Who this helps: This information is valuable for patients considering their treatment options and for doctors planning care for vestibular schwannoma.

PubMed

Quantification of CD3, FoxP3, and granzyme B immunostaining in canine renal cell carcinoma.

2024

Veterinary immunology and immunopathology

Cournoyer A, Amerman H, Assenmacher CA, Durham A, Perry JA +4 more

Plain English
This study looked at the immune cells present in kidney tumors of dogs with renal cell carcinoma to understand how they affect the dogs’ health. Researchers found that the tumors had few immune cells, and a higher presence of a specific type of immune cell (FoxP3) was linked to worse outcomes for the dogs. This matters because it helps us understand how these tumors avoid the immune system, which could lead to better treatments in the future. Who this helps: This helps veterinarians and researchers working to improve cancer treatments for dogs.

PubMed

[Treatment of localized rectal cancer in 2024].

2024

Revue medicale suisse

Baudoux N, Meyer J, Durham A, Corro C, Ris F +3 more

Plain English
Researchers studied how to better treat localized rectal cancer by comparing more intense treatment methods, like combining chemotherapy and radiation before surgery, with less intense approaches. They found that the intense treatments led to better results for the most advanced tumors, while patients who had a complete response to initial treatment could safely choose to avoid surgery altogether. This research is important because it offers new options for patients, improving outcomes while reducing unnecessary surgeries. Who this helps: This helps patients with localized rectal cancer and their doctors.

PubMed

Editorial: Neuropsychiatric disorders in the veterans volume II: emerging evidence of precision medicine and complementary and integrative health (CIH) approaches.

2024

Frontiers in psychiatry

Pasinetti GM, Ashford JW, Durham A, Shah D, Saxena V +1 more

PubMed

Hyperthermia and radiotherapy: physiological basis for a synergistic effect.

2024

Frontiers in oncology

Righini MF, Durham A, Tsoutsou PG

Plain English
This study looks at combining mild heat treatment (hyperthermia) with radiation therapy to make cancer treatment more effective without adding extra side effects. The authors explain that using heat can damage cancer cells and improve the impact of radiation therapy by targeting various biological processes, including DNA damage and immune responses. Understanding how these treatments work together is important for developing new and better cancer therapies. Who this helps: This helps patients with cancer by potentially improving their treatment options.

PubMed

Very early symptomatic metastasis pseudoprogression after stereotactic brain radiosurgery in a melanoma patient treated with BRAF/MEK inhibitors: a case report and review of the literature.

2024

Frontiers in oncology

Romano E, Tran S, Ben Aissa A, Carvalho Goncalves M, Durham A +1 more

Plain English
This study looked at a 61-year-old melanoma patient who had brain tumors while being treated with a specific drug combination (dabrafenib and trametinib) and received focused radiation therapy (SRS). Just four days after the first radiation session, the patient experienced a seizure, and scans showed that the tumors initially appeared to worsen, but they later shrank significantly within a month. This case is important because it reveals a new potential side effect of radiation in patients taking these targeted drugs, urging careful monitoring and more research on how these treatments interact. Who this helps: This helps patients with melanoma and their doctors by improving understanding of treatment effects.

PubMed

Lung stereotactic radiation therapy: Intercomparison of irradiation devices in terms of outcome and predictive factors.

2023

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Le Reun E, Casutt A, Durham A, Bouchaab H, Romano E +5 more

Plain English
This study looked at three different types of radiation therapy devices used for treating lung tumors: CyberKnife, Helical Tomotherapy, and volumetric modulated arc therapy. Researchers analyzed data from 111 patients and found that CyberKnife was effective in treating tumors while using a smaller area of healthy tissue, leading to lower side effects. Specifically, CyberKnife had a lower volume of healthy lung exposed to radiation, which reduced the risk of complications. Who this helps: This research benefits patients undergoing lung cancer treatment by identifying the safest and most effective radiation therapy option.

PubMed

Functional trait-based restoration alters nutrient cycling and invasion rates in Hawaiian lowland wet forest.

2023

Ecological applications : a publication of the Ecological Society of America

DiManno N, Ostertag R, Uowolo A, Durham A, Blakemore K +2 more

Plain English
The study looked at ways to restore degraded forests in Hawaii and found that planting a mix of native and non-native tree species can slow down nutrient cycling and reduce the invasion of unwanted species. After five years, they discovered that experimental forest communities had lower nutrient cycling rates than the invaded forest, and those that used a combination of species traits were better at resisting invasive plants. This matters because controlling nutrient levels and limiting invasive species can help restore native forests more effectively. Who this helps: This benefits forest managers and conservationists working to restore native ecosystems in Hawaii.

PubMed

Isolation of circulating tumor cells to diagnose melanoma and evaluate the efficacy of surgical resection using melanoma-specific microsystem.

2022

Advanced nanobiomed research

Kang YT, Mutukuri A, Hadlock T, Fairbairn H, Carle TR +8 more

Plain English
This study looked at a new way to diagnose melanoma, a serious type of skin cancer, using a special device called MelanoBean that detects cancer cells in the blood. Researchers found that melanoma patients had significantly more of these cancer cells compared to healthy individuals, and after surgery, the number of cancer cells decreased sharply. This is important because it means doctors can more easily monitor how well treatment is working and potentially catch recurrences earlier. Who this helps: This helps patients with melanoma and their doctors.

PubMed

NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.

2021

Journal of the National Comprehensive Cancer Network : JNCCN

Swetter SM, Thompson JA, Albertini MR, Barker CA, Baumgartner J +28 more

Plain English
This study reviews important updates to the NCCN guidelines for treating skin melanoma, focusing on new recommendations for surgery, pathology, and treatment options. Key changes include improved guidelines for removing tumors, conducting lymph node biopsies, and managing advanced disease with systemic therapies. These updates aim to provide better patient outcomes and more effective treatment strategies. Who this helps: This helps patients with melanoma and their doctors by offering clearer treatment paths.

PubMed

Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanoma.

2021

Oncotarget

Potu H, Kandarpa M, Peterson LF, Durham A, Donato NJ +1 more

Plain English
This study explored how blocking a specific enzyme, Usp9x, affects a protein called SOX2 in melanoma cancer cells with BRAF mutations. Researchers found that reducing Usp9x led to more SOX2 being broken down, which made melanoma cells more likely to die when treated with BRAF inhibitors; this combination treatment completely stopped tumor growth in lab settings. This finding is important because it offers a new way to tackle melanoma, especially in patients who have tumors resistant to existing therapies. Who this helps: This helps melanoma patients, especially those with BRAF mutations who have limited treatment options.

PubMed

NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.

2020

Journal of the National Comprehensive Cancer Network : JNCCN

Rao PK, Barker C, Coit DG, Joseph RW, Materin M +31 more

Plain English
This study looked at the latest guidelines for managing uveal melanoma, a rare type of eye cancer. It provided clear steps for diagnosing, treating, and monitoring patients, especially when it's tricky to tell if a growth is cancerous or not. The guidelines emphasize thorough testing and follow-up to ensure patients get the right care—helping doctors determine who really needs treatment and who can be monitored safely. Who this helps: This benefits patients with uveal melanoma and their doctors.

PubMed

Dual-Isolation and Profiling of Circulating Tumor Cells and Cancer Exosomes from Blood Samples with Melanoma Using Immunoaffinity-Based Microfluidic Interfaces.

2020

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Kang YT, Hadlock T, Lo TW, Purcell E, Mutukuri A +7 more

Plain English
This study looked at a new method for detecting melanoma, a serious type of skin cancer, by analyzing blood samples. Researchers found that melanoma patients had between 0 and 17 circulating tumor cells (CTCs) and an average of 299 micrograms of cancer exosomes per milliliter of blood, while healthy people had fewer than 2 CTCs and about 75.6 micrograms of exosomes. This approach is important because it provides a noninvasive way to monitor the disease and could help identify important markers for its progression and treatment effectiveness. Who this helps: This helps melanoma patients and their doctors.

PubMed

Folate Receptor Overexpression in Human and Canine Meningiomas-Immunohistochemistry and Case Report of Intraoperative Molecular Imaging.

2019

Neurosurgery

Pierce JT, Cho SS, Nag S, Zeh R, Jeon J +5 more

Plain English
Researchers studied meningiomas, which are typically benign brain tumors, to see if they produce a specific protein called folate receptor alpha (FRα) that could help identify these tumors during surgery. They found that 89% of grade I meningiomas, 67% of grade II, and 50% of grade III tumors in humans overexpressed FRα, and all seven canine meningioma samples did as well. This is important because using a special dye that targets FRα can enhance imaging during surgery, helping doctors remove the tumor more effectively and reducing the chance of leaving any cancerous tissue behind. Who this helps: This helps patients undergoing surgery for meningiomas.

PubMed

Immunoglobulin G from single plasma donor in immune globulin intravenous causes false positive pyrogen test.

2019

Biologicals : journal of the International Association of Biological Standardization

Zervos C, Zimmerman TP, Willis T, Flexman G, Srivastava J +8 more

Plain English
This study looked into why several batches of a medication called IGIV-C failed a safety test in rabbits that checks for fever-causing substances. Researchers found that plasma from one specific donor caused these test failures, and even a small amount (one unit) of this donor's plasma in a large pool of about 4500 units was enough to trigger a positive result. This is important because ensuring the safety of medications, especially those given intravenously, is crucial for preventing adverse reactions in patients. Who this helps: This benefits patients receiving IGIV-C and the doctors who prescribe it.

PubMed

Evaluation of Aminolevulinic Acid-Derived Tumor Fluorescence Yields Disparate Results in Murine and Spontaneous Large Animal Models of Lung Cancer.

2019

Scientific reports

Predina JD, Runge J, Newton A, Mison M, Xia L +7 more

Plain English
This study looked at how well a special fluorescent dye, used in surgery for lung cancer, works in different animal models. The researchers found that while the dye made lung tumors glow in most dogs (6 out of 7), the results were mixed, and it struggled to provide accurate readings for tumor edges and nearby lymph nodes. This matters because it highlights the need for better testing methods in animals that closely mimic humans to improve surgical outcomes for lung cancer. Who this helps: This helps patients undergoing lung cancer surgery and their doctors.

PubMed

Chronic equine hepacivirus infection in an adult gelding with severe hepatopathy.

2019

Veterinary medicine and science

Tegtmeyer B, Echelmeyer J, Pfankuche VM, Puff C, Todt D +6 more

Plain English
This study looked at a horse that had severe liver disease and found it was also infected with equine hepacivirus (EqHV), a virus related to hepatitis C in humans. The horse showed clear signs of chronic infection, with the virus present in its liver tissue. This is significant because while EqHV has mostly been linked to mild infections in horses, this case demonstrates it might also be involved in serious liver issues. Who this helps: This research helps veterinarians and horse owners understand the potential risks of EqHV in equine health.

PubMed

Novel inverse planning optimization algorithm for robotic radiosurgery: First clinical implementation and dosimetric evaluation.

2019

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Zeverino M, Marguet M, Zulliger C, Durham A, Jumeau R +5 more

Plain English
This study examined a new algorithm called VOLO™ for planning robotic radiosurgery treatments, specifically comparing its effectiveness to the older Sequential Optimization (SO) algorithm for patients with various tumors, including brain, spine, prostate, and lung. The researchers looked at 50 treatment plans and found that VOLO™ improved target coverage and reduced delivery time by an average of 20%, while providing better dose distribution for some tumor types, although SO performed better in certain conditions, like in prostate treatments. This matters because it shows potential improvements in treatment efficiency and effectiveness, which can lead to better patient outcomes. Who this helps: This helps patients undergoing robotic radiosurgery.

PubMed

Targeting Mitochondrial Oxidative Stress to Mitigate UV-Induced Skin Damage.

2018

Frontiers in pharmacology

Brand RM, Wipf P, Durham A, Epperly MW, Greenberger JS +1 more

Plain English
This study looked at how exposure to UV radiation can damage skin by overwhelming its natural defenses and causing issues like DNA damage. Researchers found that certain natural and synthetic compounds can help reduce the harmful effects of UV radiation at the cellular level, particularly in the mitochondria, which are vulnerable to damage. This is important because it could lead to effective ways to prevent skin aging and cancer caused by UV exposure. Who this helps: This helps patients looking for better protection and treatments against UV-related skin damage.

PubMed

Can Segmentectomy Still Be Proposed As an Alternative to Lobectomy in 2016?

2017

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

De Bari B, Durham A, Bourhis J, Ozsahin M

PubMed

Impaired innate immune gene profiling in airway smooth muscle cells from chronic cough patients.

2017

Bioscience reports

Rossios C, Pavlidis S, Gibeon D, Mumby S, Durham A +7 more

Plain English
This study looked at airway smooth muscle cells (ASMCs) from patients with chronic cough and compared them to those from healthy individuals to understand how their immune responses differ, especially after simulating a viral infection. Researchers found that, after exposure to a viral mimic, patients with chronic cough had 212 genes that were activated differently compared to 1,674 in healthy subjects, indicating a stronger response in healthy individuals. This distinction suggests that chronic cough may be influenced more by changes in immune cell behavior rather than the presence of additional immune cells or nerves. Who this helps: This helps patients with chronic cough by providing insights into possible biological mechanisms behind their symptoms.

PubMed

Phosphatidylinositol transfer protein-α in platelets is inconsequential for thrombosis yet is utilized for tumor metastasis.

2017

Nature communications

Zhao L, Thorsheim CL, Suzuki A, Stalker TJ, Min SH +6 more

Plain English
This study looked at a protein called PITPα in platelets and its role in blood clotting and tumor spread. Researchers found that mice without PITPα in their platelets form normal blood clots but have 80% less signaling that helps tumors spread, resulting in fewer lung tumors when injected with cancer cells. This matters because it shows that certain functions of platelets are separate—some are important for stopping bleeding while others are crucial for cancer growth. Who this helps: This helps patients with cancer by potentially guiding new treatment strategies.

PubMed

Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma.

2017

Nature communications

Potu H, Peterson LF, Kandarpa M, Pal A, Sun H +6 more

Plain English
This study looked at how a protein called Usp9x influences another protein, Ets-1, which plays a role in melanoma, a type of skin cancer. The researchers found that high levels of Usp9x and Ets-1 were present in more aggressive forms of melanoma, and blocking Usp9x could reduce tumor growth by preventing Ets-1 from promoting cancer-related genes. Their findings show that targeting Usp9x might be a promising strategy for melanoma treatment. Who this helps: This helps patients with melanoma and their doctors by offering potential new treatment options.

PubMed

Intraoperative near-infrared fluorescence imaging and spectroscopy identifies residual tumor cells in wounds.

2015

Journal of biomedical optics

Holt D, Parthasarathy AB, Okusanya O, Keating J, Venegas O +7 more

Plain English
This study looked at a new imaging method using near-infrared fluorescence to find leftover cancer cells in patients' wounds during surgery. It was tested on 15 dogs and 2 humans, where it successfully identified remaining tumor cells in most cases; specifically, it found significant tumor cell presence in 4 out of 5 dogs with a strong fluorescent signal. This is important because it means that this imaging technique could help surgeons ensure they remove all cancer cells, reducing the chance of cancer returning after surgery. Who this helps: This benefits patients undergoing surgery for tumors.

PubMed

Rapid diagnosis of strangles (Streptococcus equi subspecies equi) using PCR.

2015

Research in veterinary science

Cordoni G, Williams A, Durham A, Florio D, Zanoni RG +1 more

Plain English
Researchers focused on improving the diagnosis of strangles, a serious horse disease caused by a specific bacteria. They developed two new tests that can quickly and accurately detect the bacteria responsible for strangles, achieving a 95% success rate in identifying true cases and a 98% rate in avoiding false positives. This is important because faster diagnosis can help prevent the disease from spreading among horses, which is crucial for their health and welfare. Who this helps: Horse owners and veterinarians.

PubMed

Risk factors associated with lymphedema after lymph node dissection in melanoma patients.

2015

American journal of surgery

Friedman JF, Sunkara B, Jehnsen JS, Durham A, Johnson T +1 more

Plain English
This study looked at the factors that can lead to lymphedema, a swelling condition, in melanoma patients who underwent surgery to remove lymph nodes. Out of 269 patients, 56 (about 21%) developed lymphedema after surgery. The study found that those who had surgery on inguinal lymph nodes or had peripheral vascular disease were significantly more likely to experience lymphedema, with the risk being more than four times greater for inguinal surgeries and almost four times greater for patients with vascular issues. Who this helps: This information benefits melanoma patients and their doctors by helping them understand the risks associated with lymph node surgery.

PubMed

Using bioinformatics tools to study the role of microRNA in cancer.

2014

Methods in molecular biology (Clifton, N.J.)

Passetti F, Jorge NA, Durham A

Plain English
This research focused on using advanced technology called high-throughput sequencing to study microRNA, a type of genetic material, in cancerous and normal tissues. The researchers found that comparing microRNA levels in tumor and healthy tissues helps identify which microRNAs are expressed differently in cancer. This is significant because understanding these differences can lead to better cancer detection and treatment strategies. Who this helps: This benefits cancer patients and doctors by improving diagnostic methods and treatment options.

PubMed

Comment on Suthers and colleagues.

2013

Equine veterinary journal

Durham A

PubMed

Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT.

2013

Bone marrow transplantation

Sauter CT, Bailey CP, Panis MM, Biswas CS, Budak-Alpdogan T +3 more

Plain English
This study looked at how a protein called IL-15 affects cancer-fighting cells in mice that received stem cell transplants from partially matching donors. Researchers found that giving IL-15 along with a small number of donor T-cells made the treatment much more effective at fighting tumors, improving survival rates significantly. Specifically, those treated with IL-15 and a low dose of T-cells showed better anti-tumor responses compared to those who only received IL-15. Who this helps: This benefits patients undergoing stem cell transplants for leukemia by potentially improving their treatment outcomes.

PubMed

Infection with Toxoplasma gondii alters lymphotoxin expression associated with changes in splenic architecture.

2012

Infection and immunity

Glatman Zaretsky A, Silver JS, Siwicki M, Durham A, Ware CF +1 more

Plain English
This study looked at how the Toxoplasma gondii parasite affects immune responses in mice, focusing on changes in the spleen. Researchers found that the infection led to an increase in specific immune cells but caused a significant restructuring of the spleen, which temporarily impaired its organization. Even though spleen removal slowed down the immune response, the mice eventually produced normal levels of antibodies against the parasite, highlighting the spleen's role in fighting this infection. Who this helps: This research benefits doctors and scientists working on improving immune responses to infections.

PubMed

Pemphigus herpetiformis: report of a rare case.

2012

Journal of the American Academy of Dermatology

Durham A, Carlos CA, Gudjonsson JE, Lowe L, Hristov AC

PubMed

Notch1 is not required for acinar-to-ductal metaplasia in a model of Kras-induced pancreatic ductal adenocarcinoma.

2012

PloS one

Avila JL, Troutman S, Durham A, Kissil JL

Plain English
The study investigated whether a protein called Notch1 is necessary for a process (acinar-to-ductal metaplasia, or ADM) that occurs in the early stages of pancreatic cancer driven by a mutated gene called K-ras. Researchers found that while K-ras alone is enough to trigger ADM, removing Notch1 did not significantly change how ADM happened; however, mice without Notch1 had more pancreatic lesions, indicating that Notch1 may actually make acinar cells less likely to develop these lesions. This research is important because it helps us understand the early changes in pancreatic cancer and could lead to new treatment strategies. Who this helps: This helps patients at risk for pancreatic cancer and doctors treating them.

PubMed

Frequent Co-Authors

Thibaud Koessler Frederic Ris Aurélie Bornand Jeremy Meyer Divyash Shah Giorgos Karakousis Sunil Singhal David Holt Kristof Egervari Claudia Corrò

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.